logo

Molecular Cell Biology Assignment

   

Added on  2022-07-28

7 Pages2030 Words15 Views
Running head: MOLECULAR CELL BIOLOGY
MOLECULAR CELL BIOLOGY
Name of the Student:
Name of the University:
Author’s Note:

MOLECULAR CELL BIOLOGY1
“What Should We Know to Better Treat Coronavirus Infections?”
The coronavirus pandemic will come to an end one day maybe in a few months or a
year. However, with knowledge, the situation would have been different. COVID-19 is
thought to serve as a mega-decibel wake-up call for the entire world. The first case if
COVID-19 was located in Wuhan, China, in the middle of November 2019 and since the
number of affected cases rose. The first reaction of the Chinese government was to deny the
fact and then cover it up. In the month of December, results from various laboratories
indicated that there was an outbreak of a new virus, which was similar to that of Severe Acute
Respiratory Syndrome or SARS 1 (Zhang & Liu. 2020). However, the government did not
act upon it. In December, a doctor from Wuhan, Li Wenliang released the evidence on the
internet who was penalised for spreading rumours and later died due to the disease (BBC
News, 2020). On 14 January, the World Health Organisation (WHO) had stated that in the
preliminary testing by the Chines authorities, there was no evidence of human-to-human
transmission. However, six days later, China admitted that the virus could be transmitted
through; however; it was too late, as the disease had travelled across the world. Currently,
there are 2407400 affected cases and 165071 deaths in the world and the most affected areas
are the USA, Spain, Italy and other European countries (Worldometers.info, 2020).
The callousness of the Chinese government was one of the deadliest reason of the
outbreak of the virus in all over the world; however, it can be stated that there is a lack of
knowledge that did not allow the healthcare as well as the scientific community to offer
testing and treatment options to reduce the burden of the disease. As per WHO, it a novel
virus and it spread through droplet transmission. There are no vaccine or treatment options
available due to the lack of knowledge in the research community (Yuen et al., 2020). It is
tagged as a ‘novel’ virus due to insufficient data resulted in the illness. The commencement
of research had been initiated latterly and it can be stated that for the investigators, the

MOLECULAR CELL BIOLOGY2
recognition of the new coronavirus as the cause of severe acute respiratory syndrome was a
remarkable yet known fact. This is because they had worked with the family of viruses for
more than 30 years. Thus, the feature of coronavirus related to biology, disease and
pathogenesis was familiar in nature. The studies conducted by the research indicated that the
replication of this virus has several mechanisms that can be repeated and thus, persistent
infection occur. Patel et al. (2020) opined that the high rate of mutation and the
recombination of RNA-RNA hinder the virus from being extraordinarily adaptable and thus,
have the capability of regaining and acquiring virulence from time-to-time. Recently
considerable efforts have been made in finding various aspects of the virus and explaining the
factors that have been occurring such a high rate of deaths in the world. These challenges
have posed a significant challenge in drug discovery and vaccine development (Li et al.,
2020). The scientific community was not aware of such havoc that may have taken place as a
result; they had directly they focus on the existing diseases. The major gaps in the knowledge
were related to the origin, duration of virus lifecycle, transmission mode, epidemiology and
clinical spectrum of the disease. From the recent outbreak, various information has been
collected that allowed in gaining understanding (Li et al., 2020). The common symptoms at
the onset of the illness among the patients include fever, cough and fatigue with less common
signs, including sputum production, diarrhoea and headache. The patients had pneumonia
with abnormal findings examines from the chest CT scan (Lam et al., 2020). The challenges
in the research are due to the fact that it is a unique pathogen that is different from the
previous SARS outbreak and thus, adaptability in a different manner to humans. The
adaptation results in a faster spread, better replication, better cell entry and in some cases, it
helps in the reduction of the fatality rate.
From various researches and studies, it can be seen that the researcher primarily
thought it to be similar to the previous SARS outbreak and reliable of it to strategies. As a

End of preview

Want to access all the pages? Upload your documents or become a member.

Related Documents
Respiratory Complications And Covid-19
|7
|1677
|22

Clinical Update on COVID-19 Virus: Aetiology, Pathophysiology, Clinical Manifestations, Diagnostic Process, and Treatment
|11
|2861
|134

THE MOLECULAR CELL BIOLOGY
|9
|1316
|31

Covid-19: Is it Manmade?
|6
|1455
|123

Essay on COVID 19
|7
|1992
|165

The disease was formally named Corona Virus
|7
|1672
|11